Severine Vermeire
0000-0001-9942-3019
11 papers found
Refreshing results…
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State
Venous thromboembolism in patients with psoriasis: a retrospective single-centre chart review of an overlooked comorbidity
High Acetate Concentration Protects Intestinal Barrier and Exerts Anti-Inflammatory Effects in Organoid-Derived Epithelial Monolayer Cultures from Patients with Ulcerative Colitis
What are the Unmet Needs and Most Relevant Treatment Outcomes According to Patients with Inflammatory Bowel Disease? A Qualitative Patient Preference Study
A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis
Venous thrombotic events in psoriasis patients: a systematic review with meta-analysis
Long-term safety of vedolizumab for inflammatory bowel disease
Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients with Crohn's Disease
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease
Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses
Missing publications? Search for publications with a matching author name.